Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-499
Closed -$221K – 160
2021
Q2
$221K Sell
499
-675
-57% -$295K 0.07% 135
2021
Q1
$492K Sell
1,174
-100
-8% -$39.9K 0.14% 112
2020
Q4
$522K Hold
1,274
– – 0.16% 97
2020
Q3
$527K Hold
1,274
– – 0.21% 80
2020
Q2
$494K Sell
1,274
-100
-7% -$37.4K 0.16% 98
2020
Q1
$431K Buy
1,374
+465
+51% +$157K 0.17% 111
2019
Q4
$333K Hold
909
– – 0.24% 82
2019
Q3
$232K Hold
909
– – 0.29% 74
2019
Q2
$241K Hold
909
– – 0.31% 75
2019
Q1
$242K Hold
909
– – 0.29% 75
2018
Q4
$260K Hold
909
– – 0.33% 75
2018
Q3
$308K Hold
909
– – 0.28% 84
2018
Q2
$271K Hold
909
– – 0.21% 96
2018
Q1
$244K Hold
909
– – 0.15% 107
2017
Q4
$225K Hold
909
– – 0.1% 118
2017
Q3
$221K Buy
+909
New +$223K 0.11% 110

Other funds holding HUM

Matisse Capital's HUM Position: Q3 2021 in Review

Matisse Capital sold out of Humana (HUM) in Q3 2021, closing a stake of 499 shares — an estimated $221K sold.

Matisse Capital first reported a position in HUM in Q3 2017 and held it in 16 quarters. The position peaked at $527K in Q3 2020. 853 funds tracked by Wall St. Rank hold HUM as of Q3 2021.

  • Matisse Capital reported no remaining Humana position as of Q3 2021 after selling out during the quarter.
  • Matisse Capital sold 499 Humana shares in Q3 2021, an estimated $221K.
  • Matisse Capital first reported a position in Humana in Q3 2017 and held it in 16 quarters.
  • Matisse Capital's Humana position peaked at $527K in Q3 2020.
  • 853 funds tracked by Wall St. Rank held Humana as of Q3 2021.

Based on Matisse Capital's 13F filing for Q3 2021, filed 8 Nov 2021.